OBJECTIVES: This study assessed the importance of socioeconomic status, race, and likelihood of receiving surgery in explaining mortality among patients with stage-I non-small cell lung cancer. METHODS: Analyses focused on Black and White individuals 75 years of age and younger (n = 5189) diagnosed between 1980 and 1982 with stage-I non-small cell lung cancer in Detroit, San Francisco, and Seattle. The main outcome measure was months of survival after diagnosis. RESULTS: Patients in the highest income decile were 45% more likely to receive surgical treatment and 102% more likely to attain 5-year survival than those in the lowest decile. Whites were 20% more likely to undergo surgery than Blacks and 31% more likely to survive 5 years. Multivariate procedures controlling for age and sex confirmed these observations. CONCLUSIONS: Socioeconomic status and race appear to independently influence likelihood of survival. Failure to receive surgery explains much excess mortality.
OBJECTIVES: This study assessed the importance of socioeconomic status, race, and likelihood of receiving surgery in explaining mortality among patients with stage-I non-small cell lung cancer. METHODS: Analyses focused on Black and White individuals 75 years of age and younger (n = 5189) diagnosed between 1980 and 1982 with stage-I non-small cell lung cancer in Detroit, San Francisco, and Seattle. The main outcome measure was months of survival after diagnosis. RESULTS:Patients in the highest income decile were 45% more likely to receive surgical treatment and 102% more likely to attain 5-year survival than those in the lowest decile. Whites were 20% more likely to undergo surgery than Blacks and 31% more likely to survive 5 years. Multivariate procedures controlling for age and sex confirmed these observations. CONCLUSIONS: Socioeconomic status and race appear to independently influence likelihood of survival. Failure to receive surgery explains much excess mortality.
Authors: J L Young; C L Percy; A J Asire; J W Berg; M M Cusano; L A Gloeckler; J W Horm; W I Lourie; E S Pollack; E M Shambaugh Journal: Natl Cancer Inst Monogr Date: 1981-06
Authors: Lisa R Shugarman; Melony E S Sorbero; Haijun Tian; Arvind K Jain; J Scott Ashwood Journal: Am J Public Health Date: 2007-10-30 Impact factor: 9.308
Authors: Michael Z Caposole; Kaylee Miller; Jehovah-Nissi Kim; Nancy A Steward; Thomas L Bauer Journal: Surg Oncol Date: 2014-02-20 Impact factor: 3.279
Authors: Norma E Farrow; Selena J An; Paul J Speicher; David H Harpole; Thomas A D'Amico; Jacob A Klapper; Matthew G Hartwig; Betty C Tong Journal: J Thorac Cardiovasc Surg Date: 2019-11-13 Impact factor: 5.209
Authors: Michael K Gould; Ellen M Schultz; Todd H Wagner; Xiangyan Xu; Sharfun J Ghaus; Robert B Wallace; Dawn Provenzale; David H Au Journal: J Thorac Oncol Date: 2011-05 Impact factor: 15.609
Authors: Laura-Mae Baldwin; Sharon A Dobie; Kevin Billingsley; Yong Cai; George E Wright; Jason A Dominitz; William Barlow; Joan L Warren; Stephen H Taplin Journal: J Natl Cancer Inst Date: 2005-08-17 Impact factor: 13.506
Authors: Alison L Van Dyke; Michele L Cote; Geoffrey M Prysak; Gina B Claeys; Angie S Wenzlaff; Valerie C Murphy; Fulvio Lonardo; Ann G Schwartz Journal: Carcinogenesis Date: 2008-05-02 Impact factor: 4.944
Authors: Fasiha Kanwal; Jennifer R Kramer; Hashem B El-Serag; Susan Frayne; Jack Clark; Yumei Cao; Thomas Taylor; Donna Smith; Donna White; Steven M Asch Journal: Clin Infect Dis Date: 2016-04-30 Impact factor: 9.079
Authors: Christelle Clément-Duchêne; Shannon Stock; Xiangyan Xu; Ellen T Chang; Scarlett Lin Gomez; Dee W West; Heather A Wakelee; Michael K Gould Journal: Ann Am Thorac Soc Date: 2016-01